Five Trends That Will Shape the Future of Obesity Care in India: Ajanta Pharma Shares Its Perspective on the Next Decade of Metabolic Health

Five Trends That Will Shape the Future of Obesity Care in India: Ajanta Pharma Shares Its Perspective on the Next Decade of Metabolic Health

Shaping the future of cardiometabolic innovation: advances and opportunities - Nature Metabolism

A salute to innovation: exenatide in diabetes and obesity drug development at Amylin Pharmaceuticals - Nature Metabolism

Obesity care's next generation will combine GLP-1 drugs with personalized therapies and advanced procedures

The article discusses how GLP-1 drugs like Ozempic, Wegovy, and Zepbound have transformed obesity treatment, but experts predict the future

The Lancet Summit: shaping the future of diabetes prevention

Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows

This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p